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Edited by Laszlo NagyAbstract The distribution of selenium in mammals has been
recently shown to be mediated primarily by selenoprotein P.
Even in the absence of selenoprotein P, selenium is distributed
from the liver into all organs and tissues when supplemented in
the diet. The form of selenium that is actively taken up by mam-
malian cells at trace concentrations has yet to be determined. We
used a human keratinocyte model to determine whether reduction
of the oxyanion selenite ðSeO23 Þ to the more reduced form of
selenide (HSe) would aﬀect uptake. Indeed a reduced form of
selenium, presumably selenide, was actively transported into
keratinocytes and displayed saturation kinetics with an apparent
Km of 279 nM. ATPase inhibitors blocked the uptake of selenide,
as did the competing anions molybdate and chromate, but not
sulfate. These results suggest that the small molecule form of
selenium that is distributed in tissues is hydrogen selenide,
despite its sensitivity to oxygen and reactivity to thiols.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Keratinocyte1. Introduction
The metalloid selenium is a required micronutrient in mam-
mals needed for insertion into speciﬁc selenoproteins [1]. Two
groups of selenoenzymes, isoenzymes of glutathione peroxi-
dase and thioredoxin reductase, are the best studied of these
selenoproteins [1]. Given the importance of these enzymes in
antioxidant defense it is clear that optimal selenium nutrition
has an impact on the balance of oxidants to antioxidants.
The adsorption of selenium has been well studied in animals
and humans, usually comparing selenate, selenite and seleno-
methionine for their ability to serve as nutritional sources of
selenium [2,3]. Although the pathways for insertion of sele-
nium into selenoproteins are becoming better understood in
mammals [4,5], the transport of selenium at the molecular level
into individual cells is poorly understood.
The metabolism of selenium upstream of the enzyme seleno-
phosphate synthetase (SPS) [6,7] is poorly understood, yet it is
clear that selenium must ﬁrst be reduced to selenide since thisAbbreviations: DIDS, 4,4 0-diisothiocyanatostilbene-2,2 0-disulfonate;
DCCD, N,N 0-dicyclohexylcarbodiimide; RSSeSR, selenotrisulﬁde;
CCCP, carbonyl cyanide m-chlorophenylhydrazone
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teria and mammals [5,8]. This reduction has long been pre-
sumed to be mediated by thiols in a reaction known as the
Painter reaction [9]. Painter described the reduction of selenite
to selenide after reduction by cysteine, and subsequent work
by Ganther revealed the reactivity with the abundant cellular
thiol glutathione [10–12]. A selenotrisulﬁde (RSSeSR) interme-
diate in this reductive pathway has been characterized for a
variety of thiols [10,13–15]. It has been speculated that this
form of selenium (RSSeSR) might be abundant in the cell,
although in vitro evidence suggests these compounds are quite
sensitive to high concentrations of reduced thiols [10–13].
Nonetheless, through the Painter reaction, eﬃcient reduction
of selenium to selenide can occur if reduced thiols such as glu-
tathione are abundant. Reduced glutathione is known to be
present in millimolar quantities in the cytosol of prokaryotic
or eukaryotic cells [16].
Studies that have focused on uptake of selenium have gener-
ally compared the transport of selenite or selenate to compet-
ing anions in model systems. Selenite was taken up by the same
anion transporter allowing transport of selenate and sulfate in
Salmonella typhimurium [17]. In both Clostridium pasteurianum
and in Selenonomas ruminatium selenite uptake was reduced in
the presence of uncoupling agents N,N 0-dicyclohexylcarbo-
diimide (DCCD) or carbonyl cyanide m-chlorophenylhydraz-
one (CCCP) [18,19]. A yeast model revealed two apparent
systems with aﬃnities in the low micromolar range and the
millimolar range [20], yet yeast do not make speciﬁc selenopro-
teins and as such the physiological relevance may not correlate
to higher eukaryotes. Taken together, the results from several
model systems suggest that many organisms have the ability to
accumulate selenium with varying aﬃnities and likely using
several diﬀerent uptake systems.
In mammals selenite uptake has been reported in red blood
cells and shown to be inhibited by an anion transport inhibitor
4,4 0-diisothiocyanatostilbene-2,2 0-disulfonic (DIDS) [21]. It is
unclear as to whether selenium oxyanions (selenite or selenate)
would occur in vivo given the level of reduced thiols that can
trigger the Painter reaction. Recent evidence in animal knock-
out models has clearly shown that the distribution of selenium
from the liver to tissues and organs is mediated by selenopro-
tein P [22–24]. It is also well established that even in the ab-
sence of selenoprotein P, selenium can be distributed from
the liver to all organs by an as yet unknown mechanism [22].
Recently, the ApoE2 receptor has been shown to bind to sele-
noprotein P, and to mediate uptake [25,26]. However, since
selenoprotein P is not found in appreciable amounts in most
tissues, it is clear distribution within the tissue (after degrada-
tion of selenoprotein P), must be a small molecule form that
has yet to be described.blished by Elsevier B.V. All rights reserved.
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as an oxyanion (selenite) or a more reduced form (selenite with
excess glutathione) using a keratinocyte model (HaCat).2. Materials and methods
2.1. Materials
Sodium selenite, b-mercaptoethanol and DCCD were purchased
from Acros Organics (Fair Lawn, NJ). Dithiothreitol (DTT) was ob-
tained from Amresco (Solon, OH). Reduced nicotinamide adenine
dinucleotide phosphate (NADPH) and sodium orthovanadate was
purchased from Alexis Biochemicals (Lausen, Switzerland). Sodium
molybdate was obtained from ICN Biomedicals (Aurora, OH). Thio-
redoxin was obtained from Promega (Madison, WI). Thioredoxin
reductase, DIDS, potassium chromate and iodoacetic acid were pur-
chased from Sigma–Aldrich (St. Louis, MO). 75Se radioisotope was ac-
quired from the University of Missouri Research Reactor (MURR,
Columbia, MO).
2.2. Cell culture
HaCat cell line, obtained from Dr. Norbert Fusenig (German Can-
cer Research Institute) was cultivated in as a monolayer in Dulbeccos
modiﬁcation of Eagles medium (DMEM) supplemented with L-gluta-
mine, sodium pyruvate, 4.5 g/l glucose, 10% fetal bovine serum (FBS),
100 lg/ml streptomycin and 100 IU/ml penicillin (Mediatech, Hern-
don, VA). Cells were incubated in a humidiﬁed CO2 (5%) incubator
at 37 C. Cells were cultured and harvested as previously described
[27].
2.3. 75Se uptake assay
HaCat cells were plated in 24 well dishes at approximately 50000
cells per well and allowed to reach conﬂuence. Cells were washed with
Dulbeccos modiﬁed phosphate buﬀered saline (DPBS), followed by
addition of unlabeled sodium selenite and radioisotope (2 lCi) to give
18 nM in DPBS. For the analysis of uptake of reduced selenium, re-
duced glutathione (GSH, 10 mM, pH 7.5) was added to the unlabeled
sodium selenite and radioisotope at a molar ratio (thiol to selenium) of
550 to 1. The ﬁnal concentration of GSH and radioisotope once added
to cells in DPBS was 10 lM (GSH) and 18 nM (Se). Cells were incu-
bated for 1 h at 37 C with a humidiﬁed CO2 (5%) atmosphere. CellsFig. 1. Glutathione reduction stimulates selenium uptake in HaCat cell mode
assessed after incubation of radiolabeled selenium with cells in DPBS for 60
speciﬁc activity of the radioisotope as described in Section 2. A representa
experiments (n = 6). The data is shown as means with standard deviation plwere subsequently washed with 1 ml of DPBS supplemented with
10 lM selenite (to allow for quick exchange of loosely bound selenium
to the outside of the cell) and twice with 1 ml of DPBS. DPBS was re-
moved and cells were lysed with 0.5 M NaOH and transferred to
12 · 75 mm glass culture tubes. 75Se was determined using a Model
1470 Gamma counter (Perkin–Elmer, Wellesley, ME).
2.4. Inhibition of selenium uptake
To monitor inhibition of selenium uptake the conditions described
above were utilized with the exception that the inhibitor was added
to each well for 10 min at 37 C with a humidiﬁed 5% CO2 atmosphere
in DPBS. After this brief pre-incubation step, uptake of selenium was
monitored as described above.
2.5. Selenium uptake with thiols other than GSH or an enzymatic thiol-
reducing system
Uptake was carried out as described above with the exception that
thiols other than GSH were mixed with unlabeled selenite and radio-
isotope selenium for 15 min prior to addition to cells in DPBS. Alter-
natively thioredoxin reductase (1.5 lg/ml), thioredoxin (1 lM) and
NADPH (500 lM) were incubated together in combinations with sele-
nium isotope and selenite for 15 min. Due to the acid present in the
radioisotope, this reaction was buﬀered to neutrality by the addition
of Tris (pH 8.0).3. Results
3.1. High aﬃnity uptake of selenium after reduction by GSH
In our initial experiments, the uptake of radioisotope sele-
nium (75Se) was followed in DPBS in adherent HaCat cells
over a period of 1 h. Uptake of selenite was essentially linear
over the course of 1 h (data not shown). Therefore we assessed
the uptake of selenium at a ﬁxed 1 h time point in all subse-
quent experiments to determine the characteristics of selenium
transport in the HaCat model. The uptake of selenite increased
in a linear fashion when added to the culture in concentrations
ranging from low nanomolar to 1 lmol (Fig. 1). Micromolar
or higher concentrations should not be considered physiologi-l. Uptake of selenite ðSeO23 Þ and reduced selenium ðSeO23 þGSHÞ wa
min. The concentration of selenium was varied without changing th
tive experiment is shown, taken from two independent reproducibl
otted as error of three independent culture replicates.s
e
e
Fig. 2. Selenite and selenide uptake is mediated by an anion
transporter. Cells were treated with DIDS at the concentrations
indicated for 10 min prior to addition of selenium. (A) Uptake of
selenite and (B) uptake of selenite pre-incubated with excess GSH.
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that the oxyanion selenite is not actively transported in HaCat
cells. In contrast, addition of glutathione to the selenite just
prior to addition to cells in excess led to eﬃcient uptake of sele-
nium at nanomolar concentrations (Fig. 1). Moreover, the up-
take of this reduced form of selenium displayed saturation
kinetics with an apparent Km of 279 nM (Fig. 1). These results
strongly suggest that selenium, in a reduced form after reduc-
tion by the thiol glutathione, is actively transported by a high-
aﬃnity uptake system.
3.2. Evidence supporting high aﬃnity uptake of selenide
GSH is the most abundant reduced thiol present in mam-
mals [16]. To determine whether selenide or a selenotrisulﬁde
derivative of GSH (GSSeSG) is being taken up, we altered
the thiol containing reductant in the pre-incubation with sele-
nite. Table 1 summarizes these results. The total selenium re-
tained by the cells was calculated and reported as compared
to selenite, which is poorly taken up under these conditions
(18 nM total selenium present, 0.36% of total selenium re-
tained in the cells). Reduction of selenite with dithiothreitol
(DTT) resulted in a signiﬁcant stimulation of selenium uptake,
as compared either to selenite or selenite with GSH (Table 1).
Likewise, b-mercaptoethanol also signiﬁcantly stimulated up-
take, whereas oxidized thioredoxin had no eﬀect (Table 1).
When all the needed components of the TrxR/Trx system were
present, selenium uptake was also stimulated (10% of total
available selenium, Table 1). It has been previously shown that
TrxR/Trx is capable of reducing selenite to selenide in vitro
[28,29]. Taken together, these results strongly suggest selenide
is the form of selenium actively transported by the human Ha-
Cat cell model. These results do not support the hypothesis
that selenotrisulﬁdes are actively taken up, since the corre-
sponding conjugates (RSSeSR) of DTT or thioredoxin would
be signiﬁcantly larger than the GSH derivative. We then fur-
ther determined the properties of this high aﬃnity transport
using a series of common inhibitors.
3.3. Uptake of reduced selenium is mediated by an anion
transporter and blocked by acetylation
The reported pKa value for selenide (H2Se) is 3.8 [30], and as
such this form of selenium carries a net negative charge at pH
7.4 (HSe) in our experimental model. Given this potential an-
ionic character, we evaluated whether DIDS, a speciﬁc inhibi-
tor of mammalian anion transporters [21], would aﬀect uptake
of selenium. DIDS treatment of HaCat cells did indeed reduceTable 1
Enhancement of selenium uptake by thiols in HaCat cells demonstrates evid
Rxn Tested compoundsa Seleniu
1 Selenite (control) 0.066 ±
2 Selenite, 10 lM glutathione 0.50 ± 0
3 Selenite, 10 lM dithiothreitol 5.3 ± 0.
4 Selenite, 10 lM b-mercatoethanol 4.0 ± 0.
5 Selenite, 10 lM Trx 0.071 ±
6 Selenite, 15 lM NADPH 0.062 ±
7 Selenite, 10 lM Trx, 15 lM NADPH 0.076 ±
8 Selenite, TrxR, Trx, NAPDH 1.8 ± 0.
aThiols were pre-incubated with selenite for 10 min and then entire mixture wa
Reactions 5–8 contained either 1 lM of thioredoxin, 1.5 lg of thioredoxin r
reaction eight containing all the components to regenerate reduced thioredo
bTotal selenium retained was determined after several washes of the HaCat c
The mean of two independent experiments (with multiple replicates) is showthe level of selenium taken up by cells, whether in the form of
selenite or reduced selenium, in a concentration-dependent
manner (Fig. 2A and B). These results suggest each form is al-
lowed entry into the cell via an anion transporter. Pre-incuba-
tion of cells with micromolar levels of iodoacetic acid also
inhibited uptake of reduced selenium, with no changes to sele-
nite uptake (data not shown). This indicates that alkylation of
selenide inhibits uptake, suggesting the high aﬃnity system is
speciﬁc for the selenide anion.
3.4. Evidence supporting ATP-dependent uptake of selenide
DCCD has been shown to act as a potent inhibitor of mem-
brane-bound ATPase complexes [31]. Selenium uptake hasence for high aﬃnity uptake of selenide
m retained (picomoles) Selenium retainedb of total (%)
0.011 0.36 ± 0.063
.12 2.8 ± 0.66
64 29 ± 3.6
46 22 ± 2.6
0.02 0.39 ± 0.11
0.015 0.34 ± 0.085
0.018 0.42 ± 0.099
28 10 ± 1.6
s added to HaCat cells containing 1 ml of DPBS and incubated for 1 h.
eductase or 500 lM of NADPH in a ﬁnal volume of 30 ll, with only
xin catalytically.
ell monolayer and subsequent lysis by NaOH as described in Section 2.
n with standard deviation as the error.
Fig. 4. Inhibition by orthovanadate further implicates an ATP-
dependent process is transporting reduced selenium. Cells were treated
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and plant cell models [19,32]. In our keratinocyte model the
uptake of selenide was inhibited in a dose-dependent manner
by DCCD (Fig. 3B). Inhibition of selenite uptake was only
apparent when DCCD was present at 200 lM (Fig. 3A). This
suggests that uptake of selenide is mediated by a membrane-
associated ATP-dependent transporter.
Another well-characterized inhibitor of ATPase enzymes,
orthovanadate [33], also inhibited uptake of selenide
(Fig. 4A). Treatment of cells with orthovanadate did not alter
the uptake of selenite (Fig. 4B). Based on the results obtained
in Figs. 3 and 4, it appears that an ATP-dependent anion
transporter is responsible for uptake of selenide, and this high
aﬃnity transporter does not play a signiﬁcant role in the trans-
port of selenite.
3.5. Diﬀerential inhibition of selenium uptake by competing
anions
Previous studies in bacterial cell models have shown compet-
ing anions such as molybdate, chromate or sulfate can aﬀect
the uptake of selenite or selenate. In our model, the addition
of sulfate did not inhibit uptake of either selenite or selenide
(data not shown). This is surprising and somewhat contradicts
the notion that selenium oxyanions can gain entry into cells via
the sulfur transport mechanism. Nonetheless molybdate and
chromate both inhibited uptake of selenide in a concentra-
tion-dependent manner (Fig. 5B and D), yet had no signiﬁcant
eﬀect on selenite transport (Fig. 5A and C). These results sug-
gest strongly that these anions also are taken up by the sameFig. 3. Sensitivity of selenium uptake to the ionophore DCCD. Cells
were treated with DCCD for 10 min prior to addition of selenium. (A)
Uptake of selenite and (B) uptake of selenite pre-incubated with excess
GSH.
with orthovanadate at the concentrations indicated for 10 min prior to
addition of selenium. (A) Uptake of selenite and (B) uptake of selenite
pre-incubated with excess GSH.transporter, although one can not rule out that they negatively
aﬀect the ATPase activity of a high-aﬃnity selenide trans-
porter.4. Discussion
Recent animal models have solidiﬁed a role for selenopro-
tein P in the transport of selenium from the liver to other or-
gans in mammals [22,23]. Nonetheless selenoprotein P
deﬁcient mice are quite capable of distributing selenium when
it is supplemented in the diet [22]. A small molecule form of
selenium is likely to be distributed into cells, yet little evidence
exists in the literature to support this or to describe the form of
selenium being distributed. Our ﬁndings suggest strongly
hydrogen selenide is eﬃciently taken up by human cells with
an apparent Km in the nanomolar range (Fig. 1). Uptake of sel-
enide was inhibited by DCCD and orthovanadate, suggesting
the uptake is mediated by an ATP-dependent mechanism. A
recent study using yeast as a model also revealed evidence sel-
enide was eﬀectively taken up, although this study was focused
on selenium toxicity in a model (yeast) that does not make spe-
ciﬁc selenoproteins [34]. Diﬀerential inhibition by competing
anions also indicates selenide is likely not transported by the
same anion transporter responsible for selenite accumulation.
Once taken up by the cell, selenide would be eﬃciently used
for selenoprotein synthesis, as this is the form needed for
SPS [5]. Future studies to identify the protein(s) responsible
Fig. 5. Competing anions molybdate and chromate block uptake of reduced selenium, but not selenite in a keratinocyte model. Molybdate or
chromate was added 10 min prior to addition of selenium at the concentrations indicated. (A and C) Uptake of selenite and (B and D), uptake of
selenite after addition of excess GSH.
D. Ganyc, W.T. Self / FEBS Letters 582 (2008) 299–304 303for this high aﬃnity uptake of selenide will certainly aid in our
understanding of selenium nutrition and distribution in mam-
mals.Acknowledgement: This research was supported by Grants to WTS
from the National Institutes of Health (ES014354) and the Florida
Department of Health (05-NIR-10).References
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